This site uses cookies. By continuing to browse the site you are agreeing to our cookie policy.

I understand
None
Investor Relations
Login
Register
United Kingdom
  • About Polar Capital
    • Our Business
    • Investment Teams
    • Capacity Management
    • Stewardship and ESG
    • Senior Management
    • Client Relations
    • Press Releases
    • COVID-19
  • Our Funds
    • Our Funds
    • Explore Our Funds
    • Latest Fact Sheets
    • Fund Prices
    • Dealing

    Regional

    • Asian Stars
    • China Stars
    • Emerging Markets Income
    • Emerging Market Stars
    • European ex-UK Income
    • Japan Value
    • North American
    • UK Value Opportunities

    Thematic & Sector

    • Asian Opportunities
    • Automation & Artificial Intelligence
    • Biotechnology
    • Financial Opportunities
    • Global Insurance
    • Global Technology
    • Healthcare Blue Chip
    • Healthcare Discovery
    • Healthcare Opportunities
    • Income Opportunities

    Alternative

    • European Forager Strategy
    • Global Absolute Return
    • Global Convertible

    Investment Trusts

    • Polar Capital Global Financials Trust plc
    • Polar Capital Global Healthcare Trust plc
    • Polar Capital Technology Trust plc
  • Investment Insights
  • Literature & Prices
    • Fund Prices
    • Latest Fact Sheets
    • Literature Library
    • Tax & Reporting
    • KIIDs
  • Contact Us
  • Investor Relations
  • Register
  • Terms & Conditions
  • Privacy Notice
  • Cookie Policy
  • Glossary

Investment Insights

Investment Insights

  • Latest Insights
  • Filter by Region & Sector
  • Filter by Fund

Region

  • Asia
  • Emerging Markets
  • Europe
  • Global
  • United Kingdom
  • United States

Thematic & Sector

  • Financials
  • Healthcare
  • Insurance
  • Technology

Regional

  • Asian Stars
  • China Stars
  • Emerging Markets Income
  • Emerging Market Stars
  • European ex-UK Income
  • Japan Value
  • North American
  • UK Value Opportunities

Thematic & Sector

  • Asian Opportunities
  • Automation & Artificial Intelligence
  • Biotechnology
  • Financial Opportunities
  • Global Insurance
  • Global Technology
  • Healthcare Blue Chip
  • Healthcare Discovery
  • Healthcare Opportunities
  • Income Opportunities

Alternative

  • European Forager
  • Global Absolute Return
  • Global Convertible
Go to main site

|

Nothing found

There are currently no insights available for this .

Read the latest fund manager commentary
Explore this fund
Emerging Markets & Asia

Emerging markets in 2021 will revolve around recovery, rebound and real economic growth

2020 was a good investment year for emerging markets and although many countries did well from this perspective, COVID-19 was a huge disruptor economically. 

Jorry Nøddekær
22 Feb 2021

Most viewed insights

Emerging Markets & Asia

Year of the Ox: Are you prepared for a long-term Chinese equity bull market?

Jerry Wu2 Feb 2021
Global Convertible

Convertible bonds in 2021: Expect strong and ongoing tailwinds

Stephen McCormick, David Keetley9 Dec 2020
UK Value

How attractive are UK equities?

Georgina Hamilton, George Godber8 Feb 2021
Global Insurance

Global Insurance: 2021 outlook

Nick Martin28 Oct 2020
Global Insurance

The best underwriting market in a decade despite 2020 challenges

Dominic Evans, Nick Martin5 Jan 2021

Most viewed insights

Emerging Markets & Asia

Year of the Ox: Are you prepared for a long-term Chinese equity bull market?

Jerry Wu2 Feb 2021
Global Convertible

Convertible bonds in 2021: Expect strong and ongoing tailwinds

Stephen McCormick, David Keetley9 Dec 2020
UK Value

How attractive are UK equities?

Georgina Hamilton, George Godber8 Feb 2021
Global Insurance

Global Insurance: 2021 outlook

Nick Martin28 Oct 2020
Global Insurance

The best underwriting market in a decade despite 2020 challenges

Dominic Evans, Nick Martin5 Jan 2021

Gain access to fund commentary and webcasts

Register now
  • Terms & Conditions
  • Privacy Notice
  • Cookie Policy
  • Anti-Slavery Statement
  • Glossary
  • Contact Us

Polar Capital LLP is a limited liability partnership registered in England and Wales with registration number OC314700. It is authorised and regulated by the UK Financial Conduct Authority and is registered as an investment advisor with the US Securities & Exchange Commission. A list of members is open to inspection at the registered office, 16 Palace Street, London, SW1E 5JD, United Kingdom.

© 2021 Polar Capital. All Rights Reserved
Site by HSL

Get the latest insights sent straight to your inbox

SubscribeNot interested

Login

Please check your email address and password.
Forgot password?|Register
Back

Please enter the email address you used to register for this site. You will be sent an email to reset your password.


Sorry, we were unable to find a user with that email address.

For assistance please telephone +44 (0) 20 7227 2700 or email investor-relations@polarcapital.co.uk

We have sent you an email with instructions on how to reset your password.

ok

Terms and Conditions

CancelAccept
  • Our Funds
  • Explore Our Funds
  • Dealing

Regional

  • Asian Stars
  • China Stars
  • Emerging Markets Income
  • Emerging Market Stars
  • European ex-UK Income
  • Japan Value
  • North American
  • UK Value Opportunities

Thematic & Sector

  • Asian Opportunities
  • Automation & Artificial Intelligence
  • Biotechnology
  • Financial Opportunities
  • Global Insurance
  • Global Technology
  • Healthcare Blue Chip
  • Healthcare Discovery
  • Healthcare Opportunities
  • Income Opportunities

Alternative

  • European Forager Strategy
  • Global Absolute Return
  • Global Convertible

Investment Trusts

  • Polar Capital Global Financials Trust plc
  • Polar Capital Global Healthcare Trust plc
  • Polar Capital Technology Trust plc